Bitcoin exchange-traded funds (ETFs) saw over $7.5 billion in trading volume in the week ending October 16, 2026, despite net outflows of about $145 million. October has been marked by larger outflows compared to September, with a notable $485 million single-day exit on October 7. However, Bitcoin's price remained stable near $82,000 during this period. The overall asset base of US spot Bitcoin ETFs remains strong, with cumulative net inflows since their January 2024 launch totaling around $57 billion and assets under management exceeding $105 billion. Market watchers suggest that the heavy trading volume combined with modest outflows indicates that weak holders are not rushing to sell, making future inflows and Bitcoin price stability key points to watch.
Bitcoin ETFs traded over $7.5 billion in the week ending October 16, 2026, providing context for market activity. For readers following cryptocurrency markets on Pluang as of Oct 16, 2026 22:02 WIB, 41 out of 50 major cryptocurrencies rose today. Notable movers include ENJ at Rp538 with a 1-day change of +4.78%, GRT at Rp455 with +4.74%, and EGLD at Rp67,287 with +4.73%.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
